BUSINESS

• Tokyo Court Strikes Down Baxalta Claim against Hemlibra: Chugai
  March 29, 2018

• Janssen Files Japan NDA for Apalutamide in CRPC
  March 29, 2018

• Eisai to Quit Generic Supply Biz, Transfer Subsidiary to Nichi-Iko
  March 29, 2018

• Takeda Mulls Takeover Bid for Shire
  March 29, 2018

• Sumitomo Dainippon to Transfer Back Office Staffers to Dedicated Subsidiary
  March 28, 2018

• Tokyo Upstart Curadim In-Licenses Drug Candidate for IPF/NASH
  March 28, 2018

• Sumitomo Dainippon, Carna Bio Cut Deal on Kinase Inhibitor Research in Psychiatry/Neurology
  March 28, 2018

• Enfortumab Vedotin Gets FDA Breakthrough Status in Urothelial Cancer: Astellas/Seattle Genetics
  March 28, 2018

• Zeria Obtains Japan Rights to Veltassa from Vifor Pharma
  March 28, 2018

• Mitsubishi Tanabe Explores Creation of Drug Safety Info. Database with Drug Makers: President
  March 28, 2018

• Daiichi Sankyo to Launch Open Innovation Research on Novel Cancer Hyperthermia Therapy with Academia, Venture Capital
  March 28, 2018

• Opdivo Gains Label Expansion in South Korea: Ono
  March 27, 2018

• Shionogi, Kyoto Univ. Ink Research Collaboration for Psychiatric Disorders
  March 27, 2018

• Asahi Kasei in Licensing Pact with RaQualia to Begin Preclinical Development for Novel Neuropathic Pain Candidate
  March 27, 2018

• Stem Cell Therapy Alofisel Wins European Approval: Takeda
  March 27, 2018

• JCR Shooting for Big Chunk of 900 Billion Yen Global Lysosome Storage Disease Market with J-Brain Cargo
  March 27, 2018

• Mitsubishi Tanabe Aims to Attain Efficiency in Clinical Trials through Full-Fledged Use of Hitachi’s AI Technology
  March 27, 2018

• Japan Approves 1st Herceptin Biosimilar for Gastric Cancer
  March 26, 2018

• Shionogi Partners with CARB-X to Fight CRE Superbug
  March 23, 2018

• Thomas-Peter Hausner Named Next President of Bayer Holdings Japan
  March 23, 2018

ページ

• « 先頭
• ‹ Prev
• …
• 402
• 403
• 404
• 405
• 406
• 407
• 408
• 409
• 410
• …
• Next ›
• 最終 »